Effect of extracorporeal anticoagulation with nafamostat mesilate and continuous renal replacement therapy in sepsis complicated by acute kidney injury
Int. Journal of Clinical Pharmacology and Therapeutics · 01.02.2026 · 64 (02) · 66-74
DOI: 10.5414/cp204852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.02.2026. Verfasst von Jianfeng Zhang und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acute Kidney Injury, Continuous Renal Replacement Therapy, Anticoagulants, Benzamidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Zhang, J., Shao, H., Zhu, D., Zhang, G., & He, Y. (2026). Effect of extracorporeal anticoagulation with nafamostat mesilate and continuous renal replacement therapy in sepsis complicated by acute kidney injury. Int. Journal of Clinical Pharmacology and Therapeutics, 64(02), 66-74. https://doi.org/10.5414/cp204852
Vancouver
Zhang J, Shao H, Zhu D, Zhang G, He Y. Effect of extracorporeal anticoagulation with nafamostat mesilate and continuous renal replacement therapy in sepsis complicated by acute kidney injury. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(02):66-74. doi:10.5414/cp204852
BibTeX
@article{Zhang2026,
author = {Zhang, Jianfeng and Shao, Hongyi and Zhu, Dong and Zhang, Guowei and He, Yinyun},
title = {Effect of extracorporeal anticoagulation with nafamostat mesilate and continuous renal replacement therapy in sepsis complicated by acute kidney injury},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {02},
pages = {66--74},
doi = {10.5414/cp204852}
}
EUVIMED